Tokyo, Japan & Brussels, Belgium, April 21, 2021 – Asahi Photoproducts and Esko have showcased their breakthrough, fully automated flexo platemaking line CrystalCleanConnect at this year’s virtual.drupa event.
‘World’s First’ Recyclable PE-based Blister Packaging-Amcor develops breakthrough recyclable healthcare packagingNews:
Building on its recent track record of breakthrough innovations to deliver recyclable packaging, Amcor is today announcing customer trials of the world’s first recyclable* Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint, when compared to packaging alternatives on the market today.**
AmSky™ eliminates PVC (PolyVinyl Chloride) from the packaging by using a Polyethylene (PE) thermoform blister and lidding film. PVC can make packaging recycling more difficult or contaminate other materials if consumers attempt to recycle it. By removing PVC – whilst retaining all the benefits of pre-existing blister packaging – Amcor has created a new, recyclable solution that benefits the entire recycling process.
Amcor is currently working with several leading pharmaceutical companies to bring AmSky™ to market globally. The company expects AmSky™ to be available in the healthcare market by the second half of 2022.
The recyclability of the material was verified by cyclos-HTP, an organization based in Aachen, Germany, that provides independent assessment and certification of such environmental claims. The carbon footprint reduction is based on an Asset life-cycle assessment of a standard PVC blister with aluminum foil lidding compared with Amcor’s AmSky PE blister and lidding film. The Asset tool is certified by the Carbon Trust.
Berry Global Healthcare is launching what the company claims is the lightest dual-port blow fill seal closure currently available for large volume parenteral applications – up to 64% lighter than some competitor products. The new lightweight Cyrano™ provides an important sustainability benefit through the reduction in overall plastic usage while offering a safe and easy-to-use solution for all types of intravenous and infusion systems in hospitals and other clinical environments.
Cyrano™ uses Berry’s advanced molding technology to create extremely lightweight components that still deliver a reliable performance to safeguard product integrity, ease drug administration, and improve patient safety. The standard ready to use closure is validated for use on the latest blow-fill-seal machines and is certified to ISO 15 759.
Cyrano™’s twin in and out port design is sealed with a protective aluminum foil, offering a flat surface for fast and easy disinfection. The swift peel-off action of the foil also saves time during administration. Importantly, the foil protects each port individually, meaning one port can be opened for access while the other remains closed and sterile.
In addition, the two separate ports also offer maximum flexibility during usage, for example allowing individual sides for injection and infusion.
The silicone and rubber-free closure provides superior seal integrity for effective protection against drug spillage, tampering, microbial, chemical, and particle contamination. In addition, it offers excellent spike retention, automatically resealing after being pierced.
The bi-injected Cyrano™ is available in both medical-grade polypropylene and polyethylene to ensure maximum compatibility during filling, sterilisation, and sealing. The closure can be incorporated into blow fill seal equipment lines, with excellent welding ability for a secure fit with the bottle. The foil can be printed to enable branding and personalisation of the closure.
Muriel Combeau, Sales and Marketing Director, Berry Global Healthcare, commented: “By removing unnecessary weight and using fewer plastic elements in its manufacture, we have developed a closure that offers a valuable sustainability benefit with no compromise on performance.
Cyrano™ is a highly flexible, and also cost-efficient, solution for many types of parenteral requirements and the administering of preparations by IV or infusion. In particular, its dual port design allows greater adaptability and ease of use compared to more traditional twin cap versions.”
Certification affirms the company’s quality management systems meets ISO requirements
Auburn, AL, April 20, 2021 – Aptar CSP Technologies, a leader in material science and active packaging solutions (part of AptarGroup, Inc.), earned the International Organization for Standardization ISO 13485:2016 certification for both its U.S. and France-based plants. These internationally recognized standards set the requirements for a quality management system specific to the medical device industry.
Market trends. New products, design and technology. These topics will be explored on 27 April 2021 in a live web event organized by SACMI in collaboration with Aptar and McKinsey
Sustainability, safety, e-commerce. Three vital pillars of the post-COVID “next normal” in packaging that SACMI will explore together with packaging multinational Aptar.
Schreiner MediPharm designed the label with an integrated NFC chip precisely for the combination of the UnoPen™ and the SmartPilot™. With the NFC-Label, the drug can automatically be identified, authenticated and checked in terms of its expiration date. Due to the smart device, the time and date of the injection as well as the delivered dose are tracked and transmitted to the patient’s related smartphone app via Bluetooth.
Schott and Credence MedSystems have formed a strategic collaboration to make syringe injections safer through integration of Schott’s pre-fillable syriQ glass and the Credence Companion technology.
As reported in an Oct. 5, 2020 press release, the companies will work together to integrate the technologies and provide the pharmaceutical industry with an innovative and differentiated offering for drug delivery via prefilled syringes. The combination of Schott’s and Credence’s offerings targets a pre-validated and pre-assembled portfolio of passive integrated needle systems with various available syringe sizes made of both glass and high-quality Cyclic Olefin Copolymer materials.
“Integrating our established Companion technology with a broad variety of existing syringe barrels from Schott is an important milestone in offering innovation without change to the pharmaceutical industry,” said John Merhige, Credence’s chief commercial officer, in the press release. “This allows pharma the confidence to work with already validated systems but the freedom to choose the perfect fit from a wide portfolio.”
Fabian Stöcker, vice president of Global Strategy and Innovation at Schott Pharmaceutical Systems added, in the press release, “Having over 20 years of experience in the field of syringes, we are happy that, with this partnership and product offering, we can even go a step further to create a new, synergistic, and trusted offering for glass and polymer syringe systems that is responsive to the growing needs of the industry. To our knowledge, we will provide the first integrated needle safety system on the market with a polymer pre-fillable syringe by integrating the Credence Companion technology into our Schott TOPPAC syringes.”
The new EU Falsified Medicines Directive requires the outer packaging of any medicine to be provided with the following features
1. “Security features which make it possible for wholesalers and persons who are empowered or authorized to dispense medicines to the public to verify the authenticity of the medicine and to identify single packs
2. As well as a device which makes it possible to check if the outer packaging has been tampered with.”
Pharmapack will be organised in accordance with Informa’s AllSecure health and safety standard. As the world’s leading events’ organiser, Informa has developed a detailed set of enhanced measures to provide the highest levels of hygiene and safety at its events, providing everyone with reassurance and confidence they are participating in a safe and controlled environment.
Part of our strategy in delivering a safe, compliant and enjoyable event is making the experience as comfortable as possible for our attendees. This is why, for 2021 we have taken the decision to host all of our content digitally, in the two weeks prior to the live event.
Pharmapack is the European hub for the pharma packaging and drug delivery device industry. Taking place annually in Paris, the event unites over 5,500 attendees and 410+ exhibitors for two days of innovation, networking and education.
Diabetes patients depending on lifelong insulin treatment have to administer the vital medication to themselves using insulin pumps, syringes or pens. Ypsomed offers UnoPen™, a disposable pen with variable dose setting, for this and other multidose therapies. Schreiner MediPharm has developed an NFC-Label for this injection aid that serves as a communication interface between the injector and the SmartPilot™—an electronic pen add-on. The resulting smart device interactively supports patients in using the pen and helps them adhere to their therapy plans.
- INDUSTRY UPDATES
- OUR PRODUCTS
- Our Partners